News - Pioglitazone Hydrochloride Approved as Concomitant Therapy With Biguanides for Type 2 Diabetes in Japan

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Clinical Pharmacology

EXPLORE :

Most Read News

All News

All Webcasts / CME

All Cases

Congress Resource Centre

All Medical Resources

My Personal Edition

Warning | Privacy

Recent news - Clinical Pharmacology

	Milnacipran Alleviates Multiple Symptoms of Fibromyalgia: Presented at AAPM - (DGDispatch)
	Fentanyl Buccal Bests Immediate-Release Oxycodone for Breakthrough Pain Relief: Presented at AAPM - (DGDispatch)
	Topical Diclofenac Effective for Elderly and Younger Patients With Hand Osteoarthritis: Presented at AAPM - (DGDispatch)
	Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial - (BMJ)
	Pazopanib Shows Promising Results for Advanced Renal Cell Carcinoma - (DGNews)

News archive

Recent webcasts/CME - Clinical Pharmacology

Translating Guidelines Into Practice: An Expert Roundtable Discussion of Optimal Antiplatelet Therapy in Acute Coronary Syndrome

Current State of the Art in Antiplatelet Therapy in Clinical Practice: Results From the Field

The Future of Antiplatelet Therapy in Patients With ACS: Can We See it From Here?

Applying Evidence to Practice: Real World Challenges in Managing Patients With ACS

Deep Vein Thrombosis in Focus: Expert Perspectives on Reducing the Burden of Venous Thromboembolism

Webcasts/CME archive

Recent cases - Clinical Pharmacology

	Sigma-1 Receptor Agonist Fluvoxamine For Delirium In Patients With Alzheimer's Disease
	Olanzapine And Pulmonary Embolism, A Rare Association: A Case Report
	Anti-Inflammatory Effects Of Antidepressant And Atypical Antipsychotic Medication For The Treatment Of Major Depression And Comorbid Arthritis: A Case Report
	Etanercept And Venous Thromboembolism: A Case Series
	Polymyxin B-immobilized Fiber Column Hemoperfusion Treatment for Drug-Induced Severe Respiratory Failure: Report of Three Cases

Cases archive

my personal edition > clinical pharmacology > news

E-Mail this DGNews to a colleague

DGNews

Pioglitazone Hydrochloride Approved as Concomitant Therapy With Biguanides for Type 2 Diabetes in Japan

NEW YORK -- December 22, 2008 -- An additional indication of concomitant therapy with biguanides has been approved for pioglitazone hydrochloride (Actos) by the Ministry of Health, Labour, and Welfare in Japan, for the treatment of type 2 diabetes.

The approval is based on a randomised, double-blind, comparative study, in which the clinical usefulness of biguanides monotherapy was compared with that of biguanides plus pioglitazone hydrochloride.

Patients receiving biguanides plus pioglitazone hydrochloride showed a statistically significant difference in improving HbA1C without increasing the risk of hypoglycaemia.

Management of type 2 diabetes should also include nutritional counselling, weight reduction as needed, and exercise.

SOURCE: Takeda Pharmaceutical Company Limited

E-Mail this DGNews to a colleague To print, use this version